Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance

Diabetes, Obesity and Metabolism

Volumn 14, Issue 1, 2012, Pages 58-66

  Stubbins, R E ^a   Najjar, K ^a   Holcomb, V B ^a   Hong, J ^a   Nunez N P ^a  

^a The University of Texas at Austin   (United States)

Author keywords

Adipose tissue; Inflammation; Insulin resistance; Obesity; Oestrogen; Sex

Indexed keywords

CHLORDANE; ESTRADIOL; FATTY ACID; INSULIN; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE HYPERTROPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CELL HYPERPLASIA; CELL PROTECTION; CELL SIZE; COMORBIDITY; CONTROLLED STUDY; CYTOLOGY; FATTY ACID BLOOD LEVEL; FATTY LIVER; FEMALE; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPOLYSIS; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; OVARIECTOMY; OXIDATIVE STRESS; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 83655201131     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01488.x     Document Type: Article

References (35)

1. Ogden CL CM, McDowell MA, Flegal KM. Obesity among adults in the United States-no change since 2003-2004. NCHS data brief no 1, National Center for Health Statistics. Hyattsville, MD, 2007.
2. Jones ME, Thorburn AW, Britt KL et al. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol 2001; 79: 3-9.
3. Hao L, Wang Y, Duan Y, Bu S. Effects of treadmill exercise training on liver fat accumulation and estrogen receptor alpha expression in intact and ovariectomized rats with or without estrogen replacement treatment. Eur J Appl Physiol 2010; 109: 879-886.
4. Heine P, Taylor J, Iwamoto G, Lubahn D, Cooke P. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 2000; 97: 12729-12734.
5. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009; 150: 2109-2117.
6. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28: 521-574.
7. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006; 95: 136-147.
8. Störk S, van der Schouw YT, Grobbee DE, Bots ML. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab 2004; 15: 66-72.
9. Lobo R. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008; 60: 10-18.
10. D'Eon T, Souza S, Aronovitz M, Obin M, Fried S, Greenberg A. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005; 280: 35983-35991.
11. Nicklas BJ, Rogus EM, Colman EG, Goldberg AP. Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women. Am J Physiol 1996; 270: E72-78.
12. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 2000; 12: 583-594.
13. Boden G, She P, Mozzoli M et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005; 54: 3458-3465.
14. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
15. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
16. Naugler WE, Sakurai T, Kim S et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-124.
17. Campbell SE, Mehan KA, Tunstall RJ, Febbraio MA, Cameron-Smith D. 17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle. J Mol Endocrinol 2003; 31: 37-45.
18. Rogers N, Witczak C, Hirshman M, Goodyear L, Greenberg A. Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun 2009; 382: 646-650.
19. Núñez N, Carpenter C, Perkins S et al. Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity (Silver Spring) 2007; 15: 1980-1987.
20. Karas RH, Schulten H, Pare G et al. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 2001; 89: 534-539.
21. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033.
22. Okuno A, Tamemoto H, Tobe K et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101: 1354-1361.
23. Shimomura I, Hammer RE, Richardson JA et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 1998; 12: 3182-3194.
24. Nahant L. Quantifying western blots without expensive commercial quantification software. In: Nahant L ed., 2007. Available from URL:.
25. Li Z, Yang J, Huang H. Oxidative stress induces H2AX phosphorylation in human spermatozoa. FEBS Lett 2006; 580: 6161-6168.
26. Falini B, Flenghi L, Pileri S et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993; 142: 1359-1372.
27. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
28. Anthonsen MW, Rönnstrand L, Wernstedt C, Degerman E, Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 1998; 273: 215-221.
29. de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-955.
30. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005; 13: 322-327.
31. Jo J, Gavrilova O, Pack S et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 2009; 5: e1000324.
32. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
33. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
34. Gao H, Liang M, Bergdahl A et al. Estrogen attenuates vascular expression of inflammation associated genes and adhesion of monocytes to endothelial cells. Inflamm Res 2006; 55: 349-353.
35. Wagner AH, Schroeter MR, Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 2001; 15: 2121-2130.